Announcements

  • Journal hero image

    This Collection highlights the newest top-viewed content from Prostate Cancer and Prostatic Diseases. PCAN aims to serve as a forum for the sharing and discussion of clinical and translational research developments in all conditions of the prostate, including prostate cancer, prostatitis, and male lower urinary tract symptoms.

  • Interact with PCAN like never before, and get the latest news and research delivered straight to your feed. Follow us on Twitter at @pcan_journal.

  • Journal hero image

    In this collection we highlight and provide novel insights into important clinical and translational advances in the management of castration-resistant prostate cancer (CRPC), with a particular focus on the following three topics: 1) Concomitant Sequential Treatment in CRPC 2) New Therapeutic agents 3) The impact of ARTA and tumour’s characteristics on treatment outcome

Prostate Cancer and Prostatic Diseases is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

Editor's Choice

The Editor of Prostate Cancer and Prostatic Diseases is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers, and have been selected because readers will find them particularly interesting or useful.
Collection

Advertisement